BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karhu J, Ala- Kokko TI, Ohtonen P, Syrjälä H. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination: Quinolones and mortality in pneumonia. Acta Anaesthesiol Scand 2013;57:587-93. [DOI: 10.1111/aas.12081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Falguera M, Ramírez M. Neumonía adquirida en la comunidad. Revista Clínica Española 2015;215:458-67. [DOI: 10.1016/j.rce.2015.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sligl WI, Asadi L, Eurich DT, Tjosvold L, Marrie TJ, Majumdar SR. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit Care Med 2014;42:420-32. [PMID: 24158175 DOI: 10.1097/CCM.0b013e3182a66b9b] [Cited by in Crossref: 107] [Cited by in F6Publishing: 39] [Article Influence: 13.4] [Reference Citation Analysis]
3 Falguera M, Ramírez M. Community-acquired pneumonia. Revista Clínica Española (English Edition) 2015;215:458-67. [DOI: 10.1016/j.rceng.2015.08.003] [Reference Citation Analysis]
4 Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Yasunaga H. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis. J Infect Chemother 2019;25:1012-8. [PMID: 31227381 DOI: 10.1016/j.jiac.2019.05.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Lee JH, Kim HJ, Kim YH. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis. J Korean Med Sci 2017;32:77-84. [PMID: 27914135 DOI: 10.3346/jkms.2017.32.1.77] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
6 Vardakas KZ, Trigkidis KK, Falagas ME. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect 2017;23:234-41. [PMID: 27965070 DOI: 10.1016/j.cmi.2016.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
7 Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 2014;143:225-45. [PMID: 24631273 DOI: 10.1016/j.pharmthera.2014.03.003] [Cited by in Crossref: 237] [Cited by in F6Publishing: 207] [Article Influence: 29.6] [Reference Citation Analysis]
8 Al-Salloum J, Gillani SW, Mahmood RK, Gulam SM. Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review. J Int Med Res 2021;49:3000605211049943. [PMID: 34719987 DOI: 10.1177/03000605211049943] [Reference Citation Analysis]
9 Karhu JM, Ala-kokko TI, Ahvenjärvi LK, Rauvala E, Ohtonen P, Syrjälä HPT. Early chest computed tomography in adult acute severe community-acquired pneumonia patients treated in the intensive care unit. Acta Anaesthesiol Scand 2016;60:1102-10. [DOI: 10.1111/aas.12749] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]